Renalytix Ai Stock Gross Profit
Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.
Renalytix |
Renalytix AI Company Gross Profit Analysis
Renalytix's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Renalytix Gross Profit | 720 K |
Most of Renalytix's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Renalytix AI reported 720 K of gross profit. This is 99.97% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Renalytix Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Renalytix could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics of similar companies.Renalytix is currently under evaluation in gross profit category among its peers.
Renalytix Fundamentals
| Return On Equity | -10.73 | |||
| Return On Asset | -0.94 | |||
| Operating Margin | (9.43) % | |||
| Current Valuation | 36.84 M | |||
| Shares Outstanding | 82.96 M | |||
| Shares Owned By Insiders | 4.51 % | |||
| Shares Owned By Institutions | 4.13 % | |||
| Number Of Shares Shorted | 378.92 K | |||
| Price To Book | 18.77 X | |||
| Price To Sales | 9.85 X | |||
| Revenue | 2.29 M | |||
| Gross Profit | 720 K | |||
| EBITDA | (28.52 M) | |||
| Net Income | (33.46 M) | |||
| Cash And Equivalents | 32.36 M | |||
| Cash Per Share | 0.89 X | |||
| Total Debt | 8.54 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.48 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (30.11 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.62) X | |||
| Target Price | 2.5 | |||
| Beta | 2.1 | |||
| Market Capitalization | 22.55 M | |||
| Total Asset | 7.97 M | |||
| Retained Earnings | (211.78 M) | |||
| Working Capital | 12.2 M | |||
| Net Asset | 7.97 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Renalytix Stock
If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |